The legalization of adult-use cannabis in Germany is a direct catalyst for Canopy Growth Corp's recent stock surge. The company's plans to expand its commercial presence in Germany through its vaporizer brand and medical cannabis products are likely to be viewed positively by investors, contributing to the stock's momentum. The significant increase in trading volume compared to the average session volume further indicates heightened investor interest and potential for continued short-term gains.